PB

Pernamitta Balarama Vamsi Krishna

Active Director Director DIN 10536578
DIN 10536578 First appointment Mar 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pernamitta Balarama Vamsi Krishna

Data last updated:

Pernamitta Balarama Vamsi Krishna is a Director at Curelise Healthcare And Wellness Private Limited (since 2024).

DIN 10536578
Primary Designation Director
First Appointment 05 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Mar 20242024Active

Board colleagues of Pernamitta Balarama Vamsi Krishna

Directorship timeline

Open interactive timeline →
Curelise Healthcare And Wellness Private Limited
Premium access

Shareholding and investment profile for Pernamitta Balarama Vamsi Krishna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pernamitta Balarama Vamsi Krishna

Pernamitta Balarama Vamsi Krishna currently holds 1 directorship: Curelise Healthcare And Wellness Private Limited (Director, since 05 Mar 2024).

Pernamitta Balarama Vamsi Krishna was first appointed on 05 Mar 2024 as Director at Curelise Healthcare And Wellness Private Limited.

The current boards of Pernamitta Balarama Vamsi Krishna's companies include Sanjeev Govinda Reddy Kariganoor (Curelise Healthcare And Wellness Private Limited), Santanu Roy (Curelise Healthcare And Wellness Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available